FY 2020 REVENUES
FY 2020 CFFO
FY 2020 Oncology Orders
FY 2020 NON-GAAP EPS
R&D GROWTH in FY 2020
Varian (NYSE: VAR) today announced that Chief Executive Officer Dow Wilson, after more than 16 years with the Company, will retire upon the successful completion of the proposed combination of...
CTSI Oncology Solutions, a Varian (NYSE: VAR) company that provides oncology services for healthcare providers worldwide, has entered into a long-term, multi-year agreement with CHRISTUS Health, a...
Varian (NYSE: VAR) announced it has joined the Cancer Drug Development Forum (CDDF) as an industry partner. This makes Varian the first medical technology company to join CDDF, the leading...
Varian (NYSE: VAR) has started the installation of the cyclotron and gantry for its ProBeam® 360° single-room proton therapy system at Penn Medicine Lancaster General Health's Ann B. Barshinger...
View all press releases
View all events
In light of the pending transaction with Siemens Healthineers, Varian will not be hosting a conference call for its first quarter of fiscal year 2021 earnings.
In light of the pending transaction with Siemens Healthineers, Varian will not be hosting a conference call for its fourth quarter of fiscal year 2020 earnings.
Canceled Third Quarter Conference Call in Light of Pending Transaction with Siemens Healthineers
View more events
Q4 FY20 Earnings Results
View all quarterly results
FY19 Annual Report
FY19 Sustainability Report
View all reports
VP, Treasurer and Investor Relations
1 650 424 6081
Varian Corporate Headquarters
3100 Hansen Way
Palo Alto, CA 94304-1038
Stay up to date on the latest investor information.